Form D · Biotechnology
MASLOW HEALTH INC.
Chapel Hill, NC · CIK 0002034038
Offering snapshot reported Feb 26, 2025 · SEC filing
- Reported sold
- $20K Offering amount: $700K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Feb 24, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 1
- Minimum accepted$25,000 → $20,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 26, 2025 | Amendment | $20,000 | No comparison | 1 | SEC filing |
| Aug 16, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-521761
Simple Agreement for Future Equity
Source: Form D, filed Feb 26, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kenneth Hale King Iii | Director, Executive |
| Zachary Douglas Schrank | Director, Executive |
| Nehemiah Richard Stewart | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
141 South Rd Suite 104 E
Chapel Hill, NC, 27514
Chapel Hill, NC, 27514